相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
Tetsuro Yoshimaru et al.
SCIENTIFIC REPORTS (2014)
Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
Frederic Thuaud et al.
CHEMISTRY & BIOLOGY (2013)
PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance
R. de Leeuw et al.
ONCOGENE (2013)
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
Tetsuro Yoshimaru et al.
NATURE COMMUNICATIONS (2013)
Clinical significance of estrogen receptor phosphorylation
Leigh C. Murphy et al.
ENDOCRINE-RELATED CANCER (2011)
Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer
Josefine Bostner et al.
CLINICAL CANCER RESEARCH (2010)
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer
Jung-Won Kim et al.
CANCER SCIENCE (2009)
Preclinical modeling of endocrine response and resistance: Focus on aromatase inhibitors
Luciana F. Macedo et al.
CANCER (2008)
Long-term treatment with tamoxifen facilitates translocation of estrogen receptor α out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells
Ping Fan et al.
CANCER RESEARCH (2007)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
M Dowsett et al.
ANNALS OF ONCOLOGY (2006)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Steroid receptor regulation of epidermal growth factor signaling through src in breast and prostate cancer cells: Steroid antagonist action
A Migliaccio et al.
CANCER RESEARCH (2005)
Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor
JM Knowlden et al.
ENDOCRINOLOGY (2005)
Integration of the extranuclear and nuclear actions of estrogen
ER Levin
MOLECULAR ENDOCRINOLOGY (2005)
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
JM Gee et al.
ENDOCRINE-RELATED CANCER (2005)
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis et al.
CLINICAL CANCER RESEARCH (2005)
Estrogen-receptor biology: Continuing progress and therapeutic implications
CK Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Endocrine therapy - current benefits and limitations
RI Nicholson et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The role of Shc and insulin-like qrowth factor 1 receptor in mediating the translocation of estrogen receptor a to the plasma membrane
RX Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of cell signalling cascades by steroid hormones
BJ Cheskis
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Expression of insulin-like growth factor 1 receptor in primary breast cancer: Immunohistochemical analysis
C Shimizu et al.
HUMAN PATHOLOGY (2004)
Adaptive hypersensitivity to estrogen: Mechanism for sequential responses to hormonal therapy in breast cancer
RJ Santen et al.
CLINICAL CANCER RESEARCH (2004)
Src family kinases, key regulators of signal transduction
SJ Parsons et al.
ONCOGENE (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells
JM Knowlden et al.
ENDOCRINOLOGY (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Estrogen receptor phosphorylation
DA Lannigan
STEROIDS (2003)
P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-α and promotes hyperplasia in mammary epithelium
RA Wang et al.
EMBO JOURNAL (2002)
Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer
EJ Filardo
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer
YL Chung et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Estrogen receptor alpha in human breast cancer: Occurrence and significance
S Ali et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2000)
Estrogen receptor α rapidly activates the IGF-1 receptor pathway
S Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
